| Mental Health and Well-being of People Who Seek Help From Their Member of Parliament (NCT04203966) | King's College London | 2018-09-24 |
| Pilot Human Lab Study of Lacosamide in Alcohol Use Disorder (AUD) (NCT03897348) | University of California, San Francisco | 2018-09-17 |
| "ALCO-VR": Virtual Reality Cue Exposure Therapy for the Treatment of Alcohol Use Disorder (NCT04858061) | University of Barcelona | 2018-09-15 |
| Scale-up of Prevention and Management of Alcohol Use Disorders and Comorbid Depression in Latin America (NCT03524599) | Maastricht University | 2018-09-12 |
| Testing the Efficacy of an Online Integrated Treatment for Comorbid Alcohol Misuse and Emotional Problems (NCT03406039) | University of Manitoba | 2018-09-04 |
| Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate) (NCT03575403) | Craig Rush | 2018-09-01 |
| The Combination of Donepezil and Cognitive Training for Treating Alcohol Use Disorder (NCT04318639) | VA Connecticut Healthcare System | 2018-08-17 |
| Effect of CBT Microinterventions on Mechanisms of Behavior Change Among Adults With AUD (NCT03661853) | University of Massachusetts, Worcester | 2018-08-08 |
| Ibudilast and Withdrawal-Related Dysphoria (NCT03489850) | University of California, Los Angeles | 2018-07-16 |
| Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders (NCT03732248) | Medical University of South Carolina | 2018-07-12 |
| Collaborative and Stepped Care in Mental Health (COMET) (NCT03226743) | Universitätsklinikum Hamburg-Eppendorf | 2018-07-12 |
| Ambulatory Alcohol Detoxification With Remote Monitoring (NCT03582150) | Stanford University | 2018-07-03 |
| Validation of a Training Program for Patients With Alcohol Use Disorder (NCT03765476) | Central Institute of Mental Health, Mannheim | 2018-07-01 |
| Deep Brain Stimulation (DBS) for the Treatment of Refractory Alcohol Use Disorder (AUD): Pilot Trial (NCT03660124) | Sunnybrook Health Sciences Centre | 2018-05-25 |
| Bristol Imperial MDMA in Alcoholism Study (NCT04158778) | Imperial College London | 2018-04-18 |
| Adapting an Effective CBT for Comorbidity to a Computer-Delivered Format (NCT03300232) | University of Minnesota | 2018-04-16 |
| Transcranial Magnetic Stimulation for the Treatment of Veterans With Alcohol Use Disorders (NCT03191266) | VA Office of Research and Development | 2018-04-15 |
| Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers (NCT03271528) | Boston Medical Center | 2018-04-15 |
| CCTAP: Cognitive Control Training for Treatment of AUD-PTSD (NCT03200028) | Posit Science Corporation | 2018-04-01 |
| Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression. (NCT03265808) | Ihsan M Salloum, MD, MPH | 2018-03-18 |
| Treatment for Comorbid Social Anxiety and Alcohol Use Disorders. (NCT03428490) | University of California, Los Angeles | 2018-03-15 |
| Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders (NCT03230006) | Boston University Charles River Campus | 2018-03-01 |
| Neural and Mobile Assessment OF Behavior Change Among Problem Drinkers (NCT03457077) | New York State Psychiatric Institute | 2018-02-27 |
| Brief Online Interventions for Alcohol Use (NCT03438539) | Craig Rush | 2018-02-22 |
| Pregabalin as Treatment for Alcohol Use Disorder (NCT03256253) | New York State Psychiatric Institute | 2018-02-15 |
| Behavioral Alcohol Responses (BAR) Study (NCT03467191) | Carnegie Mellon University | 2018-02-13 |
| Neurobiology of Alcohol and Nicotine Co-Addiction (NCT03338933) | VA Office of Research and Development | 2018-02-08 |
| Minocycline for Alcohol Use Disorder (NCT03244592) | University of California, Los Angeles | 2018-01-15 |
| Resolving Psychological Stress (NCT03996876) | University of California, San Francisco | 2018-01-09 |
| Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment (NCT03424824) | Bioprojet | 2018-01-09 |
| Community Reinforcement and Family Training (CRAFT) (NCT03281057) | Kjeld Andersen | 2018-01-01 |
| Severe Alcohol-use Disorder: a tDCS and Response Inhibition Training Intervention (NCT03447054) | Brugmann University Hospital | 2018-01-01 |
| Alkontrol-herbal Effects on Alcohol Drinking (NCT03099590) | Mclean Hospital | 2018-01-01 |
| Modafinil for the Treatment of Alcohol Use Disorders (NCT03424681) | The Mind Research Network | 2017-12-11 |
| Intermittent Theta Burst for the Treatment of Alcohol Use Disorders in Veterans (NCT03291431) | Stanford University | 2017-12-01 |
| Alcohol & Metabolic Comorbidities in PLWHA: Evidence Driven Interventions (NCT03299205) | Louisiana State University Health Sciences Center in New Orleans | 2017-11-20 |
| Understanding Alcohol Reward in Social Context (NCT03449095) | University of Illinois at Urbana-Champaign | 2017-11-04 |
| Comparison of 2 Tests to Diagnose Cognitive Dysfunctions in Alcohol Disease (NCT04009707) | Centre Hospitalier Universitaire de Nīmes | 2017-11-02 |
| Medication Development in Alcoholism: Apremilast Versus Placebo (NCT03175549) | The Scripps Research Institute | 2017-11-01 |
| Addiction Risk: Psychoeducational Intervention to Change Risk Perception Among Alcohol Patients in Residential Treatment (NCT03339674) | University of Konstanz | 2017-11-01 |
| Alcohol Use and Mental Health - Pilot Test of Video-assisted Drinking Topography (NCT03314454) | University of Florida | 2017-10-12 |
| INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers (NCT02989662) | Johns Hopkins University | 2017-09-26 |
| Influence of n-Acetylcysteine Maintenance on Alcohol Effects (NCT03216954) | William Stoops | 2017-09-15 |
| Sex Differences, Cognitive Training & Emotion Processing (NCT03137654) | University of Florida | 2017-08-16 |
| Mental Contrasting With Implementation Intentions for Alcohol Use Disorders (NCT03684798) | Susanne Rösner | 2017-08-14 |
| Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics (NCT03220776) | Medical University of South Carolina | 2017-08-07 |
| Medication Development for Opioid and Alcohol Abuse (NCT03205423) | New York State Psychiatric Institute | 2017-08-01 |
| Human Laboratory Study of Varenicline for Alcohol Use Disorder (NCT03035708) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2017-05-01 |
| The Effectiveness of a Smartphone Application in the Treatment of Alcohol Use Disorder (NCT03396887) | St Patrick's Hospital, Ireland | 2017-05-01 |
| Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress (NCT02742532) | Jennifer Mitchell | 2017-04-20 |
| Brief Intervention for ICU Patients with Alcohol Use Disorders (NCT03047577) | University of Helsinki | 2017-03-30 |
| Qungasvik (Toolbox): Prevention of Alcohol/Suicide Risk in Alaska Native Youth (NCT05400135) | University of Alaska Fairbanks | 2017-03-16 |
| Intensive Referral to Al-Anon: Benefits to Concerned Others and Their Drinkers (NCT04018560) | Palo Alto Veterans Institute for Research | 2017-03-07 |
| Brain Functional Connectivity in Alcohol Use Disorder (NCT02877849) | University of Minnesota | 2017-02-09 |
| Study of Mindfulness Practice Efficacy in Alcoholic Relapse Prevention (NCT03150550) | University Hospital, Clermont-Ferrand | 2017-01-21 |
| Inpatient Alcohol Detox & Psychotherapy (NCT03988478) | Tribhuvan University, Nepal | 2017-01-01 |
| Randomized Diagnostic Trial Comparing Ethylglucuronide and Ethanol (NCT03276520) | Hospital Clinic of Barcelona | 2016-12-14 |
| Exploring Regulation and Function of Dopamine D3 Receptors in Alcohol Use Disorders: A [11C]-(+)-PHNO Study (NCT03037060) | Centre for Addiction and Mental Health | 2016-12-01 |
| Alcohol, Inflammation, and Mindfulness Study (AIM) (NCT02994043) | University of Colorado, Denver | 2016-11-09 |
| Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II (NCT02652195) | University of Utah | 2016-11-01 |
| Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action (NCT02900352) | Virginia Commonwealth University | 2016-10-01 |
| Clinical Intervention in Alcohol Use Disorder (NCT02168400) | University of Minnesota | 2016-07-07 |
| Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects (NCT03034408) | Prof. Daniele Zullino | 2016-07-01 |
| Alcohol Disorder hOsPital Treatment Trial (NCT02478489) | Boston University | 2016-06-01 |
| [C-11]NOP-1A and Alcohol Use Disorder (NCT03448016) | Rajesh Narendran | 2016-05-27 |
| Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders (NCT02582905) | Sherwood Brown, MD, PhD | 2016-05-01 |
| Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder (NCT03658330) | VA Connecticut Healthcare System | 2016-05-01 |
| Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control (NCT02949934) | Medical University of South Carolina | 2016-05-01 |
| mWELLCARE:An Integrated mHealth System for the Prevention and Care of Chronic Disease (NCT02480062) | Public Health Foundation of India | 2016-04-01 |
| Navigation Services to Avoid Rehospitalization (NavSTAR) (NCT02599818) | Friends Research Institute, Inc. | 2016-03-15 |
| Neural Mechanisms of Disulfiram Effects (NCT02735577) | New York State Psychiatric Institute | 2016-03-01 |
| Oxytocin and Stress Response in Alcohol Use Disorder (NCT03610633) | Medical University of South Carolina | 2016-03-01 |
| Effect of Hypnotherapy in Alcohol Use Disorder Compared to Motivational Interviewing. (NCT03583788) | Sykehuset Innlandet HF | 2016-02-01 |
| Baclofen in Managing Acute Alcohol Withdrawal (NCT03293017) | Universitair Ziekenhuis Brussel | 2016-02-01 |
| AABM to Decrease Problem Drinking and Impulsivity in Veterans With AUD: A Pilot Study (NCT02600832) | University of California, San Francisco | 2016-01-01 |
| Phone-based Safety Monitoring of Baclofen Prescriptions for Alcohol Use Disorder (NCT02596763) | University Hospital, Lille | 2015-12-24 |
| Internet-based vs Face-to-face Treatment for Alcohol Dependence (NCT02888002) | Karolinska Institutet | 2015-12-01 |
| A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder (NCT02511886) | Indivior Inc. | 2015-09-01 |
| Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare (NCT02544581) | SoberLink, LLC | 2015-09-01 |
| Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder (NCT02354703) | University of Maryland, Baltimore | 2015-08-01 |
| Group Version of CRAFT Compared to Self-Directed CRAFT Delivery and Non-intervention: a Three-armed RCT (NCT02510508) | IrisZorg | 2015-08-01 |
| Integrating Combined Therapies for Persons With Co-occurring Disorders (NCT02598518) | Stanford University | 2015-07-01 |
| Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users (NCT02445339) | NYU Langone Health | 2015-07-01 |
| Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial (NCT02646449) | University of Pittsburgh | 2015-06-01 |
| HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder (NCT02252536) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2015-06-01 |
| Anonymous Treatment on the Internet for Alcohol Dependence: A Randomised, Controlled Trial (NCT02377726) | Karolinska Institutet | 2015-04-01 |
| Brief Family-involved Treatment for Alcohol Use Disorder (NCT05545644) | University of New Mexico | 2015-04-01 |
| Learning and Relapse Risk in Alcohol Dependence (FP2) (NCT02615977) | Technische Universität Dresden | 2015-04-01 |
| Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders (NCT02322047) | Seattle Institute for Biomedical and Clinical Research | 2015-03-03 |
| Nalmefene in Alcohol Dependence and Borderline Personality Disorder (NCT02752503) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2015-03-01 |
| Effectiveness of Zonisamide in Alcohol Dependent Veterans (NCT02368431) | VA Office of Research and Development | 2015-03-01 |
| Relational Agent for Alcohol Screening and Treatment (NCT02030288) | VA Office of Research and Development | 2015-02-19 |
| NIAAA Natural History Protocol (NCT02231840) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2015-01-21 |
| Sustaining Patient-centered Alcohol-related Care (NCT02675777) | Kaiser Permanente | 2015-01-01 |
| Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder (NCT02461927) | VA Office of Research and Development | 2015-01-01 |
| Cognitive Remediation for Alcohol Use Disorder and Posttraumatic Stress Disorder (NCT02929979) | VA Office of Research and Development | 2015-01-01 |
| Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement: Feasibility (NCT03507075) | Mikhail Koffarnus | 2014-11-15 |
| Gabapentin for Alcohol Relapse Prevention (NCT02349477) | Medical University of South Carolina | 2014-11-01 |
| Mobile Phone-Based Motivational Interviewing in Kenya (NCT03573167) | University of Vermont | 2014-09-30 |
| Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence (NCT02210195) | The Scripps Research Institute | 2014-09-04 |